Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Collects health data and samples from people with plasma cell disorders

Gathers health information and samples from adults with plasma cell disorders for future research.

Plain-language title generated from the registry record
Registry title: The Indiana Myeloma Registry

Key facts

Where
Indianapolis, United StatesSee the site

Where in United States

  • Indiana University Simon Cancer CenterIndianapolis, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Indiana University
Trial code
NCT03616483
Record updated
29 October 2026
Original description
This is a prospective, non-interventional, observational study. The purpose of this study is to collect data and bio-specimens that will support future researchRead full original descriptionShow less

Collection of Specimens and Clinical Data to Create A Bio-repository for the Multiple Myeloma Program: The Indiana Myeloma Registry

This is a prospective, non-interventional, observational study. The purpose of this study is to collect data and bio-specimens that will support future research

Inclusion: Male or female patients ≥ 18 years of age at the time of informed consent; Has been diagnosed with or is suspected to have one of the following:; Monoclonal Gammopathy of Undetermined Significance (MGUS); Smoldering Multiple Myeloma; Multiple Myeloma; Bony or Soft Tissue Plasmacytoma; Primary Amyloidosis.

Exclusion: < 18 years of age; Have not been diagnosed with one of the following:; Monoclonal Gammopathy of Undetermined Significance (MGUS) b.Smoldering Multiple Myeloma c.Multiple Myeloma d.Bony or Soft Tissue Plasmacytoma e.Primary Amyloidosis.

ClinicalTrials.gov NCT03616483